Evidence map›Paper›PMID 36920557›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2023

Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.

Ren Hang, Guo Bai, Bin Sun, Peng Xu, Xiaofeng Sun, Guoxin Yan, Wenhao Zhang, Fang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Clinical prognostic prediction ofTranslational cancer research · 2026
    Article
  2. Review
  3. Artificial intelligence in otorhinolaryngology: current trends and application areas.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ren HangDepartment of Stomatology, Wuxi Second People's Hospital, No. 68, Zhongshan Road, Wuxi, 214001, China.
Guo BaiDepartment of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China.
Bin SunDepartment of Stomatology, Wuxi Second People's Hospital, No. 68, Zhongshan Road, Wuxi, 214001, China.
Peng XuDepartment of Stomatology, Wuxi Second People's Hospital, No. 68, Zhongshan Road, Wuxi, 214001, China.
Xiaofeng SunDepartment of Stomatology, Wuxi Second People's Hospital, No. 68, Zhongshan Road, Wuxi, 214001, China.
Guoxin YanDepartment of Stomatology, Wuxi Second People's Hospital, No. 68, Zhongshan Road, Wuxi, 214001, China.
Wenhao ZhangDepartment of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China. Surgeon.z@126.com.
Fang WangDepartment of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China. winfred1130@163.com.ORCID http://orcid.org/0000-0001-9903-6131
Wuxi No.2 People's Hospital · CNShanghai Jiao Tong University · CN

Funding

Fundamental Research Program of the Ninth People's Hospital affiliated to the Shanghai Jiao Tong University School of Medicine JYZZ158
6 · The paper itself

Abstract

purposeClassical prognostic indicators of head and neck squamous cell carcinoma (HNSCC) can no longer meet the clinical needs of precision medicine. This study aimed to establish a radiomics model to predict Granzyme A (GZMA) expression in patients with HNSCC.

methodsWe downloaded transcriptomic data of HNSCC patients from The Cancer Genome Atlas for prognosis analysis and then used corresponding enhanced computed tomography (CT) images from The Cancer Imaging Archive for feature extraction and model construction. We explored the influence of differences in GZMA expression on signaling pathways and analyzed the potential molecular mechanism and its relationship with immune cell infiltration. Subsequently, non-invasive CT radiomics models were established to predict the expression of GZMA mRNA and evaluate the correlation with the radiomics-score (Rad-score), related genes, and prognosis.

resultsWe found that GZMA was highly expressed in tumor tissues, and high GZMA expression was a protective factor for overall survival. The degree of B and T lymphocyte and natural killer cell infiltration was significantly correlated with GZMA expression. The receiver operating characteristic curve showed that the Relief GBM and RFE_GBM radiomics models had good predictive ability, and there were significant differences in the Rad-score distribution between the high- and low-GZMA-expression groups.

conclusionsGZMA expression can significantly affect the prognosis of patients with HNSCC. Enhanced CT radiomics models can effectively predict the expression of GZMA mRNA.

Indexed as

Head and Neck NeoplasmsMachine LearningGranzymesHumansPrognosisRNA, MessengerSquamous Cell Carcinoma of Head and NeckTomographyGranzymesRNA, MessengerClinical prognosisEnhanced CTGZMAHead and neck squamous cell carcinomaRadiomics

Identifiers

PMID36920557
OpenAlexW4324307116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.